With a design unchanged for over 200 years, the simple stethoscope has been given a hi-tech overhaul that has the promise of changing the face of heart disease diagnosis forever. Scientists at Imperial College in London created a computer-driven stethoscope that identifies in a matter of seconds three of the most important heart disorders and might save thousands of lives through earlier detection.
The revolutionary device is able to detect heart failure, disease of the heart valve, and irregular heart rhythm in 15 seconds, a stunning improvement for a medical instrument that has changed very little from the time it was first invented in 1816.
AI Stethoscope Revolutionizes Heart Disease Detection
While other conventional stethoscopes that only depend upon the trained ear of a doctor, the intelligent device employs algorithms of Artificial Intelligence that listen for tiny variations in heartbeat and circulation that are utterly imperceptible to the human eye.
The device, roughly the diameter of a playing card and built in California by Eko Health, functions through the combination of two diagnostic methods. Placed on the chest of a patient, it simultaneously captures an ECG of the heart’s electrical activity and the audio of the blood flowing through the heart through a built-in microphone.
This paired data acquisition is transmitted securely to cloud-hosted AI algorithms that are able to recognize issues a human physician may overlook. In a matter of seconds, the outcomes are relayed back to a smartphone, where it is indicated whether the patient is to be flagged as at-risk for one of the three disorders.
Imperial College London’s National Heart and Lung Institute’s Doctor Patrik Bächtiger described the importance: “The stethoscope design has remained the same for 200 years – until today. It is amazing that from a quick 15-second examination you take with a smart stethoscope, it is possible in a very short time for an AI test result to be delivered.”
The technology worked in a large-scale trial of some 12,000 patients across 200 UK GP surgeries. Patients with breathlessness or fatigue symptoms – common early symptoms of heart disease were recruited for the trial.
New AI Stethoscope Offers Lifesaving Early Diagnosis for Heart Conditions
The results were striking. Patients tested with the intelligent stethoscope were twice as likely to be diagnosed with heart failure when compared with patients undergoing regular testing.
Even more astounding, they were three times more likely to be diagnosed with atrial fibrillation, an irregular heartbeat that also significantly increases stroke risk. Heart valve disease detections nearly doubled in the patients tested with the smart device.
The results were unveiled at the European Society of Cardiology annual congress in Madrid, the globe’s largest heart conference, in a reflection of the global implications of the medical breakthrough.
The window of heart disease diagnosis is often a question of life and death, quite literally. Today, heart failure is diagnosed in the majority of individuals only when they present at emergency centers in a grave condition. All too often the result is that the patient loses valuable early chances at therapy that might greatly enhance quality of life and rates of survival.
A Promising AI Tool for Earlier Heart Failure Diagnosis
Dr. Mihir Kelshiker, also from Imperial College, emphasized this point: “Most people with heart failure are only diagnosed when they arrive in A&E seriously ill. This trial shows that AI-enabled stethoscopes could change that – giving GPs a quick, simple tool to spot problems earlier, so patients can get the right treatment sooner.”
While the tech is very promising, researchers confess it is far from foolproof. There is a greater chance of false positives – incorrectly identifying healthy individuals with heart disease. To account for that risk, experts only want the AI stethoscope to be used in symptomatic patients with suspected heart disease and not for mass screening of the healthy population.
In spite of this proviso, the rewards are considerable. Clinical director of the British Heart Foundation, which funded the study in part, is Dr Sonya Babu-Narayan. She observed: “With an earlier diagnosis, individuals are able to access the therapy that they require in order to live well for longer.”
This is a breakthrough in cardiovascular medicine that holds promise for treating and preventing heart disease in millions of people at risk in the future. As healthcare continues to welcome the infusion of more and more AI, devices like the intelligent stethoscope show the power of tech to supplement the human touch in medicine and not supplant it.
